Silhouette

Daniel A. Erlanson

Carmot Therapeutics, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
A novel approach to discover selective small molecule inhibitors of FABP4 and FAB
Carmot Therapeutics, Inc.
Principal Investigator
HHS 1 $300K 07/01/11 06/30/13